Delivery of 125I-NGF to the Brain via the Olfactory Route

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Drug Delivery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/10717549709051878
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Formulary for Laboratory Animals

  1999cited by this paper
• Nerve growth factor receptors

  1997cited by this paper
• Brain potential changes after intranasal vs. intravenous administration of vasopressin: evidence for a direct nose-brain pathway for peptide effects in humans.

  1996cited by this paper
• Dose-response comparison of recombinant human nerve growth factor and recombinant human basic fibroblast growth factor in the fimbria fornix model of acute cholinergic degeneration.

  1995cited by this paper
• Quantitative analysis of the olfactory pathway for drug delivery to the brain.

  1995cited by this paper
• Direct Drug Transport from the Rat Nasal Cavity to the Cerebrospinal Fluid: the Relation to the Molecular Weight of Drugs

  1995cited by this paper
• Weight Loss in Alzheimer's Disease: An International Review of the Literature

  1994cited by this paper
• Localization of neurotrophin receptors in olfactory epithelium and bulb.

  1993cited by this paper
• Human olfactory epithelium in normal aging, alzheimer's disease, and other neurodegenerative disorders

  1991cited by this paper
• Olfactory primary neurons as a route of entry for toxic agents into the CNS.

  1991cited by this paper
• Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function.

  1991cited by this paper
• Abnormal tau‐reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease

  1991cited by this paper
• Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity

  1991cited by this paper
• Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth factor, insulin and the insulin-like growth factors I and II

  1990cited by this paper
• Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture.

  1990cited by this paper
• Olfactory thresholds are associated with degree of dementia in Alzheimer's disease.

  1990cited by this paper
• Potential use of nerve growth factor to treat Alzheimer's disease

  1989cited by this paper
• Function of neurotrophic factors in the adult and aging brain and their possible use in the treatment of neurodegenerative diseases.

  1989cited by this paper
• A nose for Alzheimer's disease?

  1989cited by this paper
• Pathological changes in olfactory neurons in patients with Alzheimer's disease

  1989cited by this paper
• Ultrastructural morphology of the olfactory pathway for cerebrospinal fluid drainage in the rabbit.

  1986cited by this paper
• Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey

  1986cited by this paper
• Alzheimer's disease may begin in the nose and may be caused by aluminosilicates.

  1986cited by this paper
• Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons.

  1986cited by this paper
• Behavioural and neurochemical effects of chronic intraventricular injections of nerve growth factor in adult rats with fimbria lesions.

  1985cited by this paper
• Transport of molecules from nose to brain: transneuronal anterograde and retrograde labeling in the rat olfactory system by wheat germ agglutinin-horseradish peroxidase applied to the nasal epithelium.

  1985cited by this paper
• Gangliosides alter morphology and growth of astrocytes and increase the activity of choline acetyltransferase in cultures of dissociated septal cells

  1985cited by this paper
• Factors influencing exit of substances from cerebrospinal fluid into deep cervical lymph of the rabbit.

  1983cited by this paper
• Effects of urethane and pentobarbital anesthesia on the demonstration of retrograde and anterograde transport of horseradish peroxidase.

  1980cited by this paper
• Nerve growth factor receptors. Characterization of two distinct classes of binding sites on chick embryo sensory ganglia cells.

  1979cited by this paper
• Uptake of radioactivity by body fluids and tissues in rhesus monkeys after intravenous injection or intranasal spray of tritium-labelled oestradiol and progesterone.

  1974cited by this paper
• The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

  1973cited by this paper

• Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer’s disease

  2025cites this paper
• Nose-to-brain drug delivery: from bench to bedside

  2025cites this paper
• Polymer-based nanocarriers to transport therapeutic biomacromolecules across the blood-brain barrier.

  2025cites this paper
• Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery

  2025cites this paper
• Nose to brain strategy coupled to nano vesicular system for natural products delivery: Focus on synaptic plasticity in Alzheimer's disease

  2024cites this paper
• SKGQA, a Peptide Derived from the ANA/BTG3 Protein, Cleaves Amyloid-β with Proteolytic Activity

  2024cites this paper
• Nasal model experiments show that a collimated fluid delivers precise doses to the human olfactory cavity in the side-laying position.

  2024cites this paper
• RETRACTED ARTICLE: A promise of nose to brain delivery of bevacizumab intranasal sol–gel formulation substantiated in rat C6 glioma model

  2024cites this paper
• Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases

  2024cites this paper
• Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis

  2024cites this paper
• The Pharmacokinetics of Drugs Delivered to the Upper Nasal Space

  2023cites this paper
• Applications of Polymeric Nanoparticle in Nose to Brain Drug Delivery

  2023cites this paper
• Combined treatment of nerve growth factor and transcranical direct current stimulations to improve outcome in children with vegetative state after out-of-hospital cardiac arrest

  2023cites this paper
• Visualization and Estimation of Nasal Spray Delivery to Olfactory Mucosa in an Image-Based Transparent Nasal Model

  2023cites this paper
• Particulate matter and Alzheimer's disease: an intimate connection.

  2022cites this paper
• Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded In Situ Nasal Gel for Brain Targeting

  2022cites this paper
• Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier

  2022cites this paper
• Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential

  2022cites this paper
• Transport of nanomedicines across the blood-brain barrier: Challenges and opportunities for imaging and therapy.

  2022cites this paper
• Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases

  2022cites this paper
• Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome

  2022cites this paper
• Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery

  2022cites this paper
• The nose has it: Opportunities and challenges for intranasal drug administration for neurologic conditions including seizure clusters

  2022cites this paper
• Advanced particulate carrier-mediated technologies for nasal drug delivery

  2022cites this paper
• Nanocrystals as a master key to deliver hydrophobic drugs via multiple administration routes.

  2022cites this paper
• Intranasal interferon-beta as a promising alternative for the treatment of Alzheimer's disease

  2022cites this paper
• Olfactory Drug Aerosol Delivery with Acoustic Radiation

  2022cites this paper
• Intranasal Insulin for Alzheimer’s Disease

  2021cites this paper
• Intranasal route: The green corridor for Alzheimer's disease therapeutics

  2021cites this paper
• The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations

  2021cites this paper
• Nose to brain drug delivery of nanoformulations in the treatment of migraine

  2021cites this paper
• Oxytocin modulates local topography of human functional connectome in healthy men at rest

  2021cites this paper
• DEVELOPMENT OF RIVASTIGMINE LOADED SELF ASSEMBLED NANOSTRUCTURES OF NONIONIC SURFACTANTS FOR BRAIN DELIVERY

  2021cites this paper
• Liquid Film Translocation Significantly Enhances Nasal Spray Delivery to Olfactory Region: A Numerical Simulation Study

  2021cites this paper
• S-ketamine and intranasal application: alternatives for the castration of male suckling piglets?

  2021cites this paper
• Direct Delivery of ANA-TA9, a Peptide Capable of Aβ Hydrolysis, to the Brain by Intranasal Administration

  2021cites this paper
• Applications of direct nose-to-brain drug delivery in biomedicine, biotechnology, tissue engineering, and immunology

  2021cites this paper
• Topical delivery of nerve growth factor for treatment of ocular and brain disorders

  2021cites this paper
• Intranasal Allopregnanolone Confers Rapid Seizure Protection: Evidence for Direct Nose-to-Brain Delivery

  2021cites this paper
• Pulsatile Bi-Directional Aerosol Flow Affects Aerosol Delivery to the Intranasal Olfactory Region: A Patient-Specific Computational Study

  2021cites this paper
• Enhanced Cellular Permeation Efficiency Through Mechanical Vibration-induced Actin Cytoskeleton Changes in Human Nasal Epithelial Cells

  2021cites this paper
• Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma

  2021influential citation
• The Kainic Acid Models of Temporal Lobe Epilepsy

  2021cites this paper
• Intranasal insulin and orexins to treat age-related cognitive decline.

  2021cites this paper
• First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines

  2021cites this paper
• Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application?

  2021cites this paper
• A Study of Antidepressant Effect and Mechanism on Intranasal Delivery of BDNF-HA2TAT/AAV to Rats with Post-Stroke Depression

  2020cites this paper
• Nose-to-brain drug delivery

  2020cites this paper
• Effect of cerebrospinal fluid circulation on nose-to-brain direct delivery and distribution of caffeine in rats.

  2020cites this paper
• NDT_A_227598 637..649

  2020cites this paper
• Nose-to-Brain Translocation and Cerebral Biodegradation of Thin Graphene Oxide Nanosheets

  2020cites this paper
• Intranasal Delivery: Effects on the Neuroimmune Axes and Treatment of Neuroinflammation

  2020cites this paper
• Intranasal Insulin: a Treatment Strategy for Addiction

  2020cites this paper
• Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer's disease.

  2020cites this paper
• Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS

  2020cites this paper
• Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity

  2020cites this paper
• Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans

  2020cites this paper
• Effects of intranasally-delivered pro-nerve growth factors on the septo-hippocampal system in healthy and diabetic rats.

  2020cites this paper
• Development and evaluation of protamine-coated PLGA nanoparticles for nose-to-brain delivery of tacrine: In-vitro and in-vivo assessment

  2020cites this paper
• Non-Invasive Strategies for Nose-to-Brain Drug Delivery

  2020cites this paper
• Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis

  2020cites this paper
• Intranasal delivery of Thyroid hormones in MCT8 deficiency

  2020cites this paper
• Advances in nasal drug delivery systems

  2020cites this paper
• The Use of Peptide and Protein Vectors to Cross the Blood-Brain Barrier for the Delivery of Therapeutic Concentration of Biologics

  2020cites this paper
• Intranasal administration of erythropoietin rescues the photoreceptors in degenerative retina: a noninvasive method to deliver drugs to the eye

  2019cites this paper
• Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives

  2019cites this paper
• Current Limitations in the Treatment of Parkinson's and Alzheimer's Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers.

  2019cites this paper
• Increased Nose-to-Brain Delivery of Melatonin Mediated by Polycaprolactone Nanoparticles for the Treatment of Glioblastoma

  2019cites this paper
• Intranasal pregnenolone increases acetylcholine in frontal cortex, hippocampus, and amygdala—Preferentially in the hemisphere ipsilateral to the injected nostril

  2019cites this paper
• Do direct nose-to-brain pathways underlie intranasal oxytocin-induced changes in regional cerebral blood flow in humans? Running title: Investigating the validity of the intranasal OT route in humans

  2019cites this paper
• Do direct nose-to-brain pathways underlie intranasal oxytocin-induced changes in regional cerebral blood flow in humans?

  2019cites this paper
• Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats

  2019cites this paper
• A Review: Nose to Brain Drug Delivery for Various CNS Disorders

  2019cites this paper
• Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

  2018cites this paper
• Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose‐response, and mechanisms of delivery

  2018cites this paper
• Long-Term Non-Invasive Treatment via Intranasal Administration of Nerve Growth Factor Protects the Human Brain in Frontotemporal Dementia associated with Corticobasal Syndrome: A Pilot Study

  2018cites this paper
• Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives.

  2018cites this paper
• Navigating albumin-based nanoparticles through various drug delivery routes.

  2018cites this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cites this paper
• An overview of hypocretin based therapy in narcolepsy

  2018cites this paper
• Intranasal Nerve Growth Factor administration improves cerebral functions in a child with severe traumatic brain injury: A case report

  2017cites this paper
• Challenges of the Nose-to-Brain Route

  2017cites this paper
• Intranasal Cerebrolysin Attenuates Learning and Memory Impairments in D‐galactose‐Induced Senescence in Mice

  2017cites this paper
• INTRANASAL CHITOSAN MICROSPHERES FOR THE TREATMENT OF EPILEPSY

  2017cites this paper
• Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting

  2017cites this paper
• TRANSFERSOMES: NOVEL APPROACH FOR INTRANASAL DELIVERY

  2017cites this paper
• Development of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting

  2017cites this paper
• Nose-to-brain peptide delivery - The potential of nanotechnology.

  2017cites this paper
• Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety study

  2017cites this paper
• Nasal and Olfactory Deposition with Normal and Bidirectional Intranasal Delivery Techniques: In Vitro Tests and Numerical Simulations

  2017cites this paper
• Numerical Comparison of Nasal Aerosol Administration Systems for Efficient Nose-to-Brain Drug Delivery

  2017cites this paper
• Brain targeting by intranasal drug delivery (INDD): a combined effect of trans-neural and para-neuronal pathway

  2016cites this paper
• Still NAAG'ing After All These Years: The Continuing Pursuit of GCPII Inhibitors.

  2016cites this paper
• Thermosensitive PLA based nanodispersion for targeting brain tumor via intranasal route.

  2016cites this paper
• Formulation and device design to increase nose to brain drug delivery

  2016cites this paper
• Optimization of magnetophoretic-guided drug delivery to the olfactory region in a human nose model

  2016cites this paper
• The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor

  2016cites this paper
• Formulation of chlorpromazine Bio-nano gel using a bio-retardant from Prunus amygdalus for nose to brain targeting

  2016cites this paper
• Harnessing nanomedicine for therapeutic intervention in glioblastoma

  2016cites this paper
• Nano-ropinirole for the management of Parkinsonism: blood–brain pharmacokinetics and carrier localization

  2015influential citation